Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 70,343 | reported | 09 Sept 2020 | tx 231+1,778,344−1,354,235 |
| Regulus Therapeutics Inc. | 25,000 | reported | 05 Nov 2012 | tx 3+6,175,500−6,150,500 |
| Karyopharm Therapeutics Inc. | 16,415 | reported | 21 May 2026 | tx 18+289,914−10,606 |
| ACORDA THERAPEUTICS INC | 10,000 | reported | 02 Jun 2021 | tx 29+207,480−46,207 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 17+1,200,724−291,304 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 15,508 | 0.00 USD | |
| 31 Jul 2025 | TENDER | Sage Therapeutics, Inc. | 46,940 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 53,229 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 174,000 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 4,600 | 0.00 USD | deriv |
| 10 Apr 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 4,862 | 6.91 USD | |
| 10 Apr 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 19,964 | 0.00 USD | |
| 16 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 174,000 | 0.00 USD | deriv |
| 05 Aug 2024 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 12,273 | 8.96 USD | |
| 05 Aug 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 50,400 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 69,000 | 0.00 USD | deriv |
| 13 Feb 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 168,000 | 0.00 USD | deriv |
| 04 Aug 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 195,000 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 34,000 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 66,500 | 0.00 USD | deriv |
| 10 Nov 2022 | PURCHASE | Sage Therapeutics, Inc. | 14,500 | 34.48 USD | first after silence |
| 11 Aug 2022 | EXERCISE | Karyopharm Therapeutics Inc. | 7,576 | 1.49 USD | |
| 11 Aug 2022 | EXERCISE | Karyopharm Therapeutics Inc. | 7,576 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 23,900 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 69,920 | 0.00 USD | deriv |
| 05 Aug 2021 | PURCHASE | Sage Therapeutics, Inc. | 23,640 | 43.15 USD | |
| 16 Jun 2021 | PURCHASE | Sage Therapeutics, Inc. | 8,800 | 56.32 USD | first after silence |
| 02 Jun 2021 | GRANT_AWARD | ACORDA THERAPEUTICS INC | 10,000 | 0.00 USD | deriv |
| 21 May 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 23,900 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Sage Therapeutics, Inc. | 390,000 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 10 Nov 2022.